CJC-1295 + Ipamorelin
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: CJC-1295 + Ipamorelin Blend is the most widely researched synergistic combination in growth hormone optimization, combining GHRH (Mod GRF 1-29) and a selective ghrelin secretagogue (Ipamorelin) in a 1:1 ratio.
How it works: Natural growth hormone release requires two distinct signals: a GHRH signal to open the pituitary faucet, and a ghrelin signal to amplify the pulse while blocking somatostatin (the hormone that shuts off GH). By supplying CJC-1295 No DAC and Ipamorelin together, both pathways are activated simultaneously, generating a massive, 5x–10x amplification of natural growth hormone pulses without elevating cortisol or prolactin.
Why researchers study it: Studied for deep restorative sleep, rapid fat loss, lean muscle tone, accelerated injury recovery, collagen synthesis, and reversing the biological signs of aging.
Compound & Molecular Specifications
Certificate of Analysis StandardsFrequently Stacked with CJC-1295 No DAC (Mod GRF 1-29)
Clinically verified combinations activating complementary physiological pathways without receptor competition.
Ipamorelin (GHRP Selective)
CJC-1295 (GHRH agonist) stimulates the synthesis and transcription of Growth Hormone in pituitary somatotropes, while Ipamorelin (selective GHSR agonist) suppresses somatostatin and triggers the vesicular release pulse. Together they produce an amplified physiological GH pulse up to 5x higher than either alone.
